The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
